CLPT ClearPoint Neuro, Inc.
11.01USD-4.43%Mkt Cap: 335.85M $P/E: —2d ago
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. Th…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap335.85M USD
Enterprise Value370.43M USD
Revenue (TTM)42.28M USD
Gross Profit22.69M USD
Net Income (TTM)-25.54M USD
Revenue/Share1.45 USD
Last Price11.01 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees160
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.21
PEG0.61
EV/EBITDA-13.13
EV/Revenue8.76
P/S7.94
P/B31.19
EPS (TTM)-1.18
EPS (Forward)-1.20
52W Range
8.27013% of range30.10
52W High30.10 USD
52W Low8.270 USD
Profitability
Gross Margin61.38%
Oper. Margin-94.15%
EBITDA Margin-66.73%
Profit Margin-69.08%
ROE-91.15%
ROA-26.13%
Growth
Revenue Growth18.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.93M USD
CapEx (TTM)522.00K USD
FCF Margin-33.23%
FCF Yield-4.18%
Net Debt34.58M USD
Net Debt/EBITDA-1.23
Balance Sheet
Debt/Equity2.08
Current Ratio4.75
Quick Ratio3.75
Book Value/Sh0.35 USD
Cash/Share0.96 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateJul 27, 2016
Splits
Last Split1:40
Split DateJul 27, 2016
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)23.50 USD
Upside (mean)+113.4%
Target Range22.00 USD – 25.00 USD
22.00+113.4% to mean25.00
# Analysts2
Ownership
Shares Out.30.50M
Float26.28M
Insiders5.48%
Institutions52.48%
Short Interest
Short Ratio7.7d
Short % Float14.68%
Short % Out.14.19%
Shares Short4.33M
Short (prev mo.)4.50M
Technical
SMA 5014.34 (-23.2%)
SMA 20013.40 (-17.8%)
Beta1.29
S&P 52W Chg16.45%
Avg Vol (30d)681.34K
Avg Vol (10d)948.83K
Technical Indicators
RSI (14)35.9
MACD-0.8614
MACD Signal-0.5266
MACD Hist.-0.3348
BB Upper16.31 USD
BB Middle13.39 USD
BB Lower10.48 USD
BB Width43.54%
ATR (14)1.052 USD
Vol Ratio (20d)1.15x